ACBH vs DACL: Dividend Yield & Total Return

ACBH and DACL both write options for income. Updated Nov 13, 2026.

Return gap
+4.7 pts1 month to Nov 13, 2026: DACL ahead, total return
Fee gap
0.05 ptsA year: ACBH 0.60%, DACL 0.65%, per filings dated Aug 24, 2026 and Sep 25, 2026
Overlap
–No book read for both funds
Net flow
–Needs daily flows for both funds
The answerOne drawing that carries it.

Compare two other funds

The evidenceWhy, in charts and cards.
ACBH and DACL · 1 month

Growth of 100

ACBH −4.6%DACL +0.1%
Growth of 100 in ACBH and DACL over 1 month, Oct 14, 2026 to Nov 13, 2026, with distributions reinvested. ACBH ends at 95.4 (−4.6%), DACL at 100.1 (+0.1%).

ACBH −4.6%, DACL +0.1%: DACL +4.7 pts ahead, 1 month, Oct 14, 2026 to Nov 13, 2026.

Share

Use this comparison

Alert

ACBH and DACL flows, by email on Sundays.

One-click unsubscribe. See Privacy.

Hypothetical · drag the order size

Cost to trade

Hypothetical. A $10,000 order in DACL costs about $4.00 one way and $8.00 in and out, at a median spread of 0.08%. The 0.08% spread is DACL’s 30-day median, from REX (fund page).

Hypothetical · drag to set

Fees over time

Hypothetical. $10,000 in DACL for 10 years at 0.65% a year costs about $1,068 in fees and lost growth; ACBH at 0.60% would cost $988. Assumes 6% a year before fees, a sample rate, not a forecast.

Total return against the benchmark

Price change Cash paid Benchmark

ACBH · since launch to Nov 13, 20261.8 pts behind SPY
ACBH
−2.0%
SPY
−0.2%

1.8 pts behind SPY

ACBH since launch: paid 2.0%, price −4.0%, total −2.0%, SPY −0.2%, −1.8 pts. Data to Nov 13, 2026.

SPY

−0.2%

ACBH

−2.0%

1.8 pts behind SPY

Total return, distributions reinvested

1.8 pts behind SPY

ACBH since launch: paid 2.0%, price −4.0%, total −2.0%, SPY −0.2%, −1.8 pts. Data to Nov 13, 2026.

SPY

−0.2%

ACBH

−2.0%

1.8 pts behind SPY

2.0% of it arrived as cash. Total return, distributions reinvested. ACBH since launch: paid 2.0%, price −4.0%, total −2.0%, SPY −0.2%, −1.8 pts. Data to Nov 13, 2026.

Data to Nov 13, 2026.
DACL · since launch to Nov 13, 2026Not measured
DACL
+0.8%

Not measured

DACL since launch: paid 1.1%, price −0.3%, total +0.8%, not measured against a benchmark. Data to Nov 13, 2026.

DACL

+0.8%

1.1% as cash

Total return, distributions reinvested

Not measured

DACL since launch: paid 1.1%, price −0.3%, total +0.8%, not measured against a benchmark. Data to Nov 13, 2026.

DACL

+0.8%

1.1% of it arrived as cash. Both charts share one scale, with zero at the line. DACL since launch: paid 1.1%, price −0.3%, total +0.8%, not measured against a benchmark. Data to Nov 13, 2026.

Data to Nov 13, 2026.

Key numbers

ACBH cash paid, since launch, Sep 10, 2026
2.0%
DACL cash paid, since launch, Aug 13, 2026
1.1%
ACBH total return, since launch, Sep 10, 2026
−2.0%
DACL total return, since launch, Aug 13, 2026
+0.8%

ACBH costs 0.05 points a year less; DACL is 2.0 times larger.

Pair scorecard

Open the table

Points (pts) are percentage points.

Price changefell 4.0% (since Sep 10, 2026)fell 0.3% (since Aug 13, 2026)
Return of capital, issuer estimate57% of the Oct 21, 2026 payment
BenchmarkS&P 500, measured through SPYnot published
Expense ratio0.60%0.65%
Net assets, as of Nov 12, 2026$3.6m$7.2m
Holdings in commonnot published

The numbers behind it

Net assets on Nov 12, 2026: $3.6m for Pacer Metaurus High Income Autocallable ETF and $7.2m for REX Defensive Autocallable Income ETF.

Side by side

Open the table
FundPacer Metaurus High Income Autocallable ETF · Autocallable on SPYREX Defensive Autocallable Income ETF · Autocallable
IssuerPacerREX
Strategyautocallableautocallable
BenchmarkS&P 500 (SPY)not set
Paysnot establishednot established
Payout rate, annualized14.9%6.9%
Expense ratio0.60%0.65%
Cash paid, 1 year2.0% (since launch, Sep 10, 2026)1.1% (since launch, Aug 13, 2026)
Price change, 1 year−4.0% (since launch, Sep 10, 2026)−0.3% (since launch, Aug 13, 2026)
Total return, 1 year−2.0% (since launch, Sep 10, 2026)+0.8% (since launch, Aug 13, 2026)
Benchmark return, 1 year−0.2% (since launch, Sep 10, 2026)not published
Ahead or behind−1.8 pts (since launch, Sep 10, 2026)not available
Return of capital, latest estimatenot published57%
Age64 days92 days
Net assets, as of Nov 12, 2026$3.6m$7.2m
More

As of Nov 13, 2026. Source: ETFIQ. Cash paid: distributions over the window, as a share of the starting price. Payout rate: the latest payment, annualized, over today’s price.

The dataFull tables, method and files, one click away.

Window by window

Open the table
3 months–+0.8%–1.1%–not measured
Since launch (Not the same days: ACBH Sep 2026 · DACL Aug 2026)−2.0%+0.8%2.0%1.1%−1.8 ptsnot measured

– means no data for this window.

About ACBH

Over the period from its first trade on Sep 10, 2026 to Nov 13, 2026, ACBH paid 2.0% of its starting value in cash distributions while its price fell 4.0%. With every distribution reinvested, the fund returned −2.0%. S&P 500 (SPY) returned −0.2% over the same days, so a holder was behind by 1.8 pts. At its price on Nov 13, 2026 the latest distribution annualizes to 14.9%, paid periodically.

About DACL

Over the period from its first trade on Aug 13, 2026 to Nov 13, 2026, DACL paid 1.1% of its starting value in cash distributions while its price fell 0.3%. With every distribution reinvested, the fund returned +0.8%. At its price on Nov 13, 2026 the latest distribution annualizes to 6.9%, paid periodically. REX estimates that 57% of the distribution paid Oct 21, 2026 was a return of capital (its 19a-1 notice). That is a tax label, not a measure of erosion.

Questions people ask

Which is cheaper, ACBH or DACL?

ACBH charges 0.60% a year and DACL charges 0.65%, so ACBH is cheaper. Fees come from each fund's prospectus.

Other comparisons

Sources

More

Links are sources, not endorsements. A comparison is not a recommendation.

Copy and cite

Cite this pageCitation, APA and Markdown

ETFIQ, ACBH against DACL, data as of Nov 13, 2026. https://etfiq.com/compare/income/acbh-vs-dacl

Open data

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.